Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 54, Issue 1, 2013, Pages 99-104

  Freeman, Jane A ^a,b,c,d   Crassini, Kyle R ^a   Best, O Giles ^a,d   Forsyth, Cecily J ^c,d   Mackinlay, Naomi J ^a,d   Han, Ping ^c,d   Stevenson, William ^a,d   Mulligan, Stephen P ^a,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b SYDNEY ADVENTIST HOSPITAL   (Australia)

^c Symbion Laverty Pathology ^*  (Australia)

^d CLL Australian Research Consortium   (Australia)

Author keywords

CLL; IgG; IgG subclass infection; Immunoglobulins

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G DEFICIENCY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DYSGAMMAGLOBULINEMIA; FEMALE; HUMANS; IGG DEFICIENCY; IMMUNOGLOBULIN G; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84869093988     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.706285     Document Type: Article

References (29)

1. N atural history of stage A chronic lymphocytic leukaemia untreated patients. French Cooperative Group on Chronic Lymphocytic Leukemia. Br J Haematol 1990 ; 76: 45-57.
2. Francis S, Karanth M, Pratt G, et al. The Effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia. Cancer 2006 ; 107: 1023-1033. (Pubitemid 44291151)
3. Dearden C. Disease-specifi c complications of chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program 2008: 450- 456.
4. It ä l ä M, Helenius H, Nikoskelainen J, et al. Infections and serum IgG levels in patients with chronic lymphocytic leukemia. Eur J Haematol 1992 ; 48: 266-270.
5. Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous immunoglobulins. Ann Intern Med 1990 ; 112: 278-292. (Pubitemid 20055353)
6. B esa E C. U se of intravenous immunoglobulin in chronic lymphocytic leukemia. Am J Med 1984; 76: 209- 218. (Pubitemid 14126175)
7. B oughton B J, J ackson N, L im S, et al. R andomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia. Clin Lab Haematol 1995 ; 17: 75-80.
8. Gamm H, Huber C, Chapel H, et al. Intravenous immune globulin in chronic lymphocytic leukaemia. Clin Exp Immunol 1994; 97(Suppl. 1): 17- 20. (Pubitemid 24235261)
9. Griffiths H, B rennan V, L ea J, et al. C rossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors. Blood 1989 ; 73: 366-368. (Pubitemid 19060513)
10. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. N Engl J Med 1988; 319: 902- 907.
11. Raanani P, Gafter-Gvili A, Paul M, et al. Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis. Leuk Lymphoma 2009; 50: 764- 772.
12. Lacombe C, Gombert J, Dreyfus B, et al. Heterogeneity of serum IgG subclass defi ciencies in B chronic lymphocytic leukemia. Clin Immunol 1999 ; 90: 128-132. (Pubitemid 29162192)
13. Copson ER, Ellis BA, Westwood NB, et al. IgG subclass levels in patients with B cell chronic lymphocytic leukaemia. Leuk Lymphoma 1994 ; 14: 471-473. (Pubitemid 24282576)
14. H allek M, C heson B D, C atovsky D, et al. G uidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008 ; 111: 5446-5456.
15. M olica S. I nfections in chronic lymphocytic leukemia: Risk factors, and impact on survival, and treatment. Leuk Lymphoma 1994; 13: 203- 214. (Pubitemid 24141326)
16. Morrison VA. Infectious complications in patients with chronic lymphocytic leukemia: Pathogenesis, spectrum of infection, and approaches to prophylaxis. Clin Lymphoma Myeloma 2009 ; 9: 365-370.
17. H amblin T J. C hronic lymphocytic leukaemia. B aillieres Clin Haematol 1987 ; 1: 449-491.
18. Kay NE. Abnormal T-cell subpopulation function in CLL: Excessive suppressor (T gamma) and defi cient helper (T mu) activity with respect to B-cell proliferation. Blood 1981 ; 57: 418-420. (Pubitemid 11154606)
19. Kurec AS, Davey FR. Impaired synthesis of immunoglobulin in patients with chronic lymphocytic leukemia. Am J Hematol 1987 ; 25: 131-142. (Pubitemid 17108010)
20. Kay NE, Perri RT. Evidence that large granular lymphocytes from B-CLL patients with hypogammaglobulinemia down-regulate B-cell immunoglobulin synthesis. Blood 1989 ; 73: 1016-1019. (Pubitemid 19078381)
21. Krackhardt AM, Harig S, Witzens M, et al. T-cell responses against chronic lymphocytic leukemia cells: Implications for immunotherapy. Blood 2002 ; 100: 167-173. (Pubitemid 35177443)
22. Alexandrescu DT, Wiernik PH. Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia. Med Oncol 2008; 25: 309- 314.
23. Dicato M, Chapel H, Gamm H, et al. Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review. Cancer 1991 ; 68: 1437-1439.
24. Gribben JG. How I treat CLL up front. Blood 2010 ; 115: 187-197.
25. Linet MS, Schubauer-Berigan MK, Weisenburger DD, et al. Chronic lymphocytic leukaemia: An overview of aetiology in light of recent developments in classifi cation and pathogenesis. Br J Haematol 2007 ; 139: 672-686. (Pubitemid 350115718)
26. Davey FR, Kurec AS, Tomar RH, et al. Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia. Am J Clin Pathol 1987 ; 87: 60-65. (Pubitemid 17216826)
27. Tsai H-T, Caporaso NE, Kyle RA, et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: A prospective study. Blood 2009 ; 114: 4928-4932.
28. Hartkamp A, Mulder AH, Rijkers GT, et al. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine 2001; 19: 1671- 1677. (Pubitemid 32175727)
29. Sinisalo M, Aittoniemi J, K ä yhty H, et al. Vaccination against infections in chronic lymphocytic leukemia. Leuk Lymphoma 2003 ; 44: 649-652. (Pubitemid 36304823)